跳至主要内容
临床试验/CTRI/2024/09/074019
CTRI/2024/09/074019尚未招募2 期

A comparison of Safety of Transrectal Prostate Biopsy to Transperineal Prostate Biopsy A Randomized Controlled Trial

AIIMS BHOPAL1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2024年9月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
AIIMS BHOPAL
入组人数
500
试验地点
1
主要终点
Incidence of infectious complications within 30 days post-biopsy

研究概览

简要总结

Purpose: To compare the safety of transrectal prostate biopsy versus transperineal prostate biopsy by evaluating the incidence of infectious complications, specifically sepsis, fever, and urinary tract infections (UTIs).

Hypothesis:There is no difference in the incidence of infectious complications or patient-reported outcomes between transrectal prostate biopsy and transperineal prostate biopsy.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Outcome Assessor Blinded

入排标准

年龄范围
40.00 Year(s) 至 80.00 Year(s)(—)
性别
Male

入选标准

  • Male patients aged 40 years and above.
  • Patients with a clinical indication for prostate biopsy (elevated PSA levels, abnormal digital rectal exam, or suspicious MRI findings).
  • Patients who provide written informed consent.
  • Patients who are capable of understanding and complying with study requirements and procedures.

排除标准

  • Patients with a history of allergic reaction to iodine or antibiotics used in the study.
  • Patients with a history of rectal surgery.
  • Patients with active urinary tract infection or prostatitis at the time of biopsy.
  • Patients with immunocompromised status (e.g., HIV, ongoing chemotherapy).
  • Patients currently receiving anticoagulant therapy that cannot be safely interrupted for the biopsy procedure.
  • Patients unwilling or unable to comply with follow-up requirements.

结局指标

主要结局

Incidence of infectious complications within 30 days post-biopsy

时间窗: Incidence of infectious complications within 30 days post-biopsy

次要结局

  • a) Pain scores: Assessed using Visual Analog Scale (0-10) immediately post-procedure(b) Patient-Reported Outcome Measures (PROMs):)

研究者

发起方
AIIMS BHOPAL
申办方类型
Other [AIIMS BHOPAL]
责任方
Principal Investigator
主要研究者

Manoj yadav

AIIMS Bhopal

研究点 (1)

Loading locations...

相似试验

A randomized trial to compare the safety of two... | 临床试验